Pharmaceutical Firms Curtailing In-Person Sales Calls to Doctors
March 16 2020 - 2:29PM
Dow Jones News
By Jared Hopkins
Some drugmakers are starting to limit in-person sales calls on
doctors and their offices in response to the coronavirus
outbreak.
Merck & Co., Amgen Inc. and Amarin Corp. PLC are among the
companies that say they are temporarily halting salespeople from
doing business face-to-face.
Pharmaceutical companies for decades have relied on sales
representatives to "detail" doctors, nurses and others with pitches
to boost prescriptions.
Merck confirmed its stand-down on Monday. Amarin, which sells
heart drug Vascepa, said on Sunday it was suspending detailing
until March 30. Biotech Amgen, which sells rheumatoid-arthritis
drug Enbrel, said on Friday it was suspending the calls until April
17.
(END) Dow Jones Newswires
March 16, 2020 14:14 ET (18:14 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024
